Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 May 1;5(4):402–408. doi: 10.1111/j.1582-4934.2001.tb00175.x

Basic studies on gene therapy of human malignant melanoma by use of the human interferon β gene entrapped in cationic multilamellar liposomes.: 1. Morphology and growth rate of six melanoma cell lines used in transfection experiments with the human interferon β gene

Gh Benga 1,
PMCID: PMC6740248  PMID: 12067474

Abstract

Six cell lines of human malignant melanoma: A375, A375.2, G361, HMV‐1, MM8.1 and WM115 were seeded at densities of 1 × 104 cells/ml, 2 × 104 cells/ml or 3 × 104 cells/ml of RPMI medium supplemented with 10% fetal calf serum and antibiotics in a humidified atmosfere of 5% CO2 at 37°C. A375 cells were also grown in Dulbecco's minimum Eagle's medium (DMEM medium). The morphology was studied by phase contrast light microscopy. At 4 days after seeding the colonies of A375 cells and HMV‐1 cells were oval‐shaped, the cells were polyhedrical and were making contact with each other regularly. The remaining cells were scattered, more elongated, and made contact randomly. G361 cells and MM8.1 cells tended to form superposed layers before 100% confluency was achieved. There were great differences in the growth rate and doubling time of melanoma cells. The doubling time in day 1 was short (around 6‐12 h) in the case of A375, G361 and HMV‐1 cells, longer (around 18h) in the case of MM8.1 cells and very long (ranging between 26 and 89 h) for A375.2 and WM115 cells. There were also differences in the doubling time of cells as a function of the cell density at seeding. On the other hand, except for MM8.1 cells, there were differences between the doubling time in day 2 compared to day 1.

Keywords: malignant melanoma, cell lines, gene therapy

References

  • 1. Kulver W.K., Gene therapy A Handbook for Physicians. Mary Ann Liebert, Inc., Publishers, New York , pp. 64–70, 1994. [Google Scholar]
  • 2. Huber B.E., Gene therapy strategies for treating neoplastic disease, Ann. N. Y. Acad. Sci., 716:6–11, 1992. [DOI] [PubMed] [Google Scholar]
  • 3. Koh H.K., Cutaneous melanoma, N. Engl. J. Med., 325:171–182, 1991. [DOI] [PubMed] [Google Scholar]
  • 4. Ohtake Y., Chen J., Gamoou S., Takayanagi A., Mashima Y., Oguchi Y., Shimizu N. Ex vivo delivery of suicide genes into melanoma cells using epidermal growth factor receptor‐specific fab immunogene, Jpn. J. Cancer Res., 90:460–468, 1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Kirkwood J.M., Strawderman M.H., Ernstoff M.S., et al., Interferon alfa‐2b adjuvant therapy of high‐risk resected cutaneous melanoma: the eastern cooperative oncology group trial EST 1684, J. Clin. Oncol., 14(1):7–17, 1996. [DOI] [PubMed] [Google Scholar]
  • 6. Sparano J.A., Dutcher J.P., Interleukin‐2 for the treatment of advanced melanoma, Melanoma, 14(1):189–195, 1993. [Google Scholar]
  • 7. Nemunaitis J., Bohart C., Fong T., Meyer W., Edelman G., Paulson R.S., Orr D., Jain V., O'Brien J., Kuhn J., Kowal K.J., Burkeholder S., Bruce J., Ognoskie N., Wynne D., Martineau D., Ando D., Phase I trial of retroviral vectormediated interferon (IFN)‐γ gene transfer into autologous tumor cells in patients with metastatic melanoma, Cancer Gene Therapy, 5:292–300, 1998. [PubMed] [Google Scholar]
  • 8. Gutzmer R., Guerry D., Gene therapy for melanoma in humans, Hematol. Oncol. Clin. North America, 12:519–538, 1998. [DOI] [PubMed] [Google Scholar]
  • 9. Johns T.G., Mackay I.R., Callister K.A., Hertzog P.J., Devenish R.J., Linnane A.W., Antiproliferative potencies of interferons on melanoma cell lines and xenografts: higher efficacy of interferon‐β, J. Natl. Canc. Inst., 84:1185–1187, 1992. [DOI] [PubMed] [Google Scholar]
  • 10. Nagatani T., Okazawa H., Kambara T., Satoh K., Nishiyama T., Tokura H., Yamada R., Nakajima H., Effect of natural interferon‐β on the growth of melanoma cell lines, Melanoma Res., 8:295–299, 1998. [DOI] [PubMed] [Google Scholar]
  • 11. Nagatani T., Ichiyama S., Onuma R., Miyazawa M., Matsuzaki T., Miyagawa K., Baba N., Uchiyama M., Nakajima H., The use of DAV (DTIC, ACNU and VCR) and natural interferon β combination therapy in malignant melanoma, Acta Derm. Venerol. (Stockh), 75:494–499, 1995. [DOI] [PubMed] [Google Scholar]
  • 12. Yagi K., Noda H., Kurono M., Ohishi N., Efficient gene transfer with less cytotoxicity by means of cationic multilamellar liposomes, Biochem. Biophys. Res Comm., 196:1042–1048, 1993. [DOI] [PubMed] [Google Scholar]
  • 13. Mizuno M., Yoshida J., Sugita K., Yagi K., Growth inhibition of glioma cells of different cell lines by human interferon‐β produced in the cells transfected with its gene by means of liposomes, J. Clin. Biochem. Nutr., 9:73–77, 1990. [Google Scholar]
  • 14. Mizuno M., Yoshida J., Sugita K., Inoue I., Seo H., Hayashi Y., Koshizaka T., Yagi K., Growth inhibition of glinoma cells transfected with the human β‐interferon gene by liposomes coupled with a monoclonal antibody, Cancer Research, 50:7826–7829, 1990. [PubMed] [Google Scholar]
  • 15. Yoshida J., Mizuno M., Yagi K., Cytotoxicity of human β‐interferon produced in human glioma cells transfected with its gene by means liposomes, Biochem. Int., 28:1055–1061, 1992. [PubMed] [Google Scholar]
  • 16. Yagi K., Mizuno M., Yoshida J., Cytotoxicity of human β‐ and γ‐interferon produced simultaneously in glioma cells transfected with interferon genes, J. Clin. Biochem. Nutr., 13:1–6, 1992. [PubMed] [Google Scholar]
  • 17. Yokoyama S., Ohishi N., Shamoto M., Watanabe Y., Yagi K., Isolation and expression of rat interferon‐β gene and growth‐inhibitory effect of its expression on rat glioma cells, Biochem. Biophys. Res. Com., 232:698–701, 1997. [DOI] [PubMed] [Google Scholar]
  • 18. Tomoda K., Ohishi N., Kikkawa F., Mizutani S., Tomoda Y., Yagi K., Cationic multilamellar liposome‐mediated human interferon‐β gene transfer into cervical cancer cell, Anticancer Res., 18:1367–1372, 1998. [PubMed] [Google Scholar]
  • 19. Shimizu M., Akiyama S., Ito K., Kasai Y., Takagi H., Kito M., Ohishi N., Yagi K., Effect on colon cancer cells of human interferon‐β gene entrapped in cationic multilamellar liposomes, Biochem. Mol. Biol. Int., 44:1235–1243, 1998. [DOI] [PubMed] [Google Scholar]
  • 20. Kito M., Akao Y., Ohishi N., Yagi K., Induction of apoptosis in cultured colon cancer cells by transfection with human interferon‐β gene, Biochem. Biophys. Res. Com., 257:771–776, 1999. [DOI] [PubMed] [Google Scholar]
  • 21. Yagi K., Hayashi Y., Ishida N., Ohbayashi M., Ohishi N., Mizuno M., Yoshida J., Interferon‐â endogenously produced by intratumoral injection of cationic liposome‐encapsulated gene: cytocidal effect on glioma transplanted into nude mouse brain, Biochem. Mol. Biol. Int., 32:167–171, 1994. [PubMed] [Google Scholar]
  • 22. Yagi K., Ohishi N., Hamada A., Shamoto M., Ohbayashi M., Ishida N., Nagata A., Kanazawa S., Nishikimi M., Basic study on gene therapy of human malignant glioma by use of the catiodic multilamellar liposome‐entrapped human interferon‐β gene, Human Gene Therapy, 10:1975–1982, 1999. [DOI] [PubMed] [Google Scholar]
  • 23. Markwell M.A.K., Hass S.M., Tolbert N.E., Bieber L.L., Protein determination in membrane and lipoprotein samples: manual and automated procedures, Meth. Enzymol., 72:296–303, 1981. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES